The Bio-identical Hormones Market is estimated to be valued at US$ 6.63 Billion in 2022 and is expected to exhibit a CAGR of 5.26% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
The Bio-identical Hormones Market refers to the pharmaceutical products that contain hormones identical in molecular structure to those naturally occurring in the human body. These hormones are derived from natural sources ... Read more
